Copyright Reports & Markets. All rights reserved.

Global and China OTC Drug Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 OTC Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key OTC Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global OTC Drug Market Size Growth Rate by Type
    • 1.4.2 Class A
    • 1.4.3 Class B
  • 1.5 Market by Application
    • 1.5.1 Global OTC Drug Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Household
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global OTC Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global OTC Drug Revenue 2015-2026
    • 2.1.2 Global OTC Drug Sales 2015-2026
  • 2.2 Global OTC Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 OTC Drug Historical Market Size by Region (2015-2020)
    • 2.3.1 Global OTC Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global OTC Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 OTC Drug Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global OTC Drug Sales Forecast by Region (2021-2026)
    • 2.4.2 Global OTC Drug Revenue Forecast by Region (2021-2026)

3 Global OTC Drug Competitor Landscape by Players

  • 3.1 Global Top OTC Drug Sales by Manufacturers
    • 3.1.1 Global OTC Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Global OTC Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global OTC Drug Manufacturers by Revenue
    • 3.2.1 Global OTC Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global OTC Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global OTC Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by OTC Drug Revenue in 2019
    • 3.2.5 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global OTC Drug Price by Manufacturers
  • 3.4 Global OTC Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 OTC Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers OTC Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into OTC Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global OTC Drug Market Size by Type (2015-2020)
    • 4.1.1 Global OTC Drug Sales by Type (2015-2020)
    • 4.1.2 Global OTC Drug Revenue by Type (2015-2020)
    • 4.1.3 OTC Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global OTC Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global OTC Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global OTC Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 OTC Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global OTC Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global OTC Drug Market Size by Application (2015-2020)
    • 5.1.1 Global OTC Drug Sales by Application (2015-2020)
    • 5.1.2 Global OTC Drug Revenue by Application (2015-2020)
    • 5.1.3 OTC Drug Price by Application (2015-2020)
  • 5.2 OTC Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global OTC Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global OTC Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global OTC Drug Price Forecast by Application (2021-2026)

6 China by Players, Type and Application

  • 6.1 China OTC Drug Market Size YoY Growth 2015-2026
    • 6.1.1 China OTC Drug Sales YoY Growth 2015-2026
    • 6.1.2 China OTC Drug Revenue YoY Growth 2015-2026
    • 6.1.3 China OTC Drug Market Share in Global Market 2015-2026
  • 6.2 China OTC Drug Market Size by Players (International and Local Players)
    • 6.2.1 China Top OTC Drug Players by Sales (2015-2020)
    • 6.2.2 China Top OTC Drug Players by Revenue (2015-2020)
  • 6.3 China OTC Drug Historic Market Review by Type (2015-2020)
    • 6.3.1 China OTC Drug Sales Market Share by Type (2015-2020)
    • 6.3.2 China OTC Drug Revenue Market Share by Type (2015-2020)
    • 6.3.3 China OTC Drug Price by Type (2015-2020)
  • 6.4 China OTC Drug Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 China OTC Drug Sales Forecast by Type (2021-2026)
    • 6.4.2 China OTC Drug Revenue Forecast by Type (2021-2026)
    • 6.4.3 China OTC Drug Price Forecast by Type (2021-2026)
  • 6.5 China OTC Drug Historic Market Review by Application (2015-2020)
    • 6.5.1 China OTC Drug Sales Market Share by Application (2015-2020)
    • 6.5.2 China OTC Drug Revenue Market Share by Application (2015-2020)
    • 6.5.3 China OTC Drug Price by Application (2015-2020)
  • 6.6 China OTC Drug Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 China OTC Drug Sales Forecast by Application (2021-2026)
    • 6.6.2 China OTC Drug Revenue Forecast by Application (2021-2026)
    • 6.6.3 China OTC Drug Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America OTC Drug Market Size YoY Growth 2015-2026
  • 7.2 North America OTC Drug Market Facts & Figures by Country
    • 7.2.1 North America OTC Drug Sales by Country (2015-2020)
    • 7.2.2 North America OTC Drug Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe OTC Drug Market Size YoY Growth 2015-2026
  • 8.2 Europe OTC Drug Market Facts & Figures by Country
    • 8.2.1 Europe OTC Drug Sales by Country
    • 8.2.2 Europe OTC Drug Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific OTC Drug Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific OTC Drug Market Facts & Figures by Country
    • 9.2.1 Asia Pacific OTC Drug Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific OTC Drug Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America OTC Drug Market Size YoY Growth 2015-2026
  • 10.2 Latin America OTC Drug Market Facts & Figures by Country
    • 10.2.1 Latin America OTC Drug Sales by Country
    • 10.2.2 Latin America OTC Drug Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa OTC Drug Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa OTC Drug Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa OTC Drug Sales by Country
    • 11.2.2 Middle East and Africa OTC Drug Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Bayer HealthCare
    • 12.1.1 Bayer HealthCare Corporation Information
    • 12.1.2 Bayer HealthCare Description and Business Overview
    • 12.1.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Bayer HealthCare OTC Drug Products Offered
    • 12.1.5 Bayer HealthCare Recent Development
  • 12.2 GlaxoSmithKline (GSK)
    • 12.2.1 GlaxoSmithKline (GSK) Corporation Information
    • 12.2.2 GlaxoSmithKline (GSK) Description and Business Overview
    • 12.2.3 GlaxoSmithKline (GSK) Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 GlaxoSmithKline (GSK) OTC Drug Products Offered
    • 12.2.5 GlaxoSmithKline (GSK) Recent Development
  • 12.3 Johnson&Johnson
    • 12.3.1 Johnson&Johnson Corporation Information
    • 12.3.2 Johnson&Johnson Description and Business Overview
    • 12.3.3 Johnson&Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Johnson&Johnson OTC Drug Products Offered
    • 12.3.5 Johnson&Johnson Recent Development
  • 12.4 Pfizer
    • 12.4.1 Pfizer Corporation Information
    • 12.4.2 Pfizer Description and Business Overview
    • 12.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Pfizer OTC Drug Products Offered
    • 12.4.5 Pfizer Recent Development
  • 12.5 Sanofi
    • 12.5.1 Sanofi Corporation Information
    • 12.5.2 Sanofi Description and Business Overview
    • 12.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Sanofi OTC Drug Products Offered
    • 12.5.5 Sanofi Recent Development
  • 12.6 AstraZeneca
    • 12.6.1 AstraZeneca Corporation Information
    • 12.6.2 AstraZeneca Description and Business Overview
    • 12.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 AstraZeneca OTC Drug Products Offered
    • 12.6.5 AstraZeneca Recent Development
  • 12.7 BioGaia
    • 12.7.1 BioGaia Corporation Information
    • 12.7.2 BioGaia Description and Business Overview
    • 12.7.3 BioGaia Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 BioGaia OTC Drug Products Offered
    • 12.7.5 BioGaia Recent Development
  • 12.8 Bristol Myers Squibb
    • 12.8.1 Bristol Myers Squibb Corporation Information
    • 12.8.2 Bristol Myers Squibb Description and Business Overview
    • 12.8.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Bristol Myers Squibb OTC Drug Products Offered
    • 12.8.5 Bristol Myers Squibb Recent Development
  • 12.9 Bukwang Pharmaceutica
    • 12.9.1 Bukwang Pharmaceutica Corporation Information
    • 12.9.2 Bukwang Pharmaceutica Description and Business Overview
    • 12.9.3 Bukwang Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Bukwang Pharmaceutica OTC Drug Products Offered
    • 12.9.5 Bukwang Pharmaceutica Recent Development
  • 12.10 Chr. Hansen
    • 12.10.1 Chr. Hansen Corporation Information
    • 12.10.2 Chr. Hansen Description and Business Overview
    • 12.10.3 Chr. Hansen Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Chr. Hansen OTC Drug Products Offered
    • 12.10.5 Chr. Hansen Recent Development
  • 12.11 Bayer HealthCare
    • 12.11.1 Bayer HealthCare Corporation Information
    • 12.11.2 Bayer HealthCare Description and Business Overview
    • 12.11.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Bayer HealthCare OTC Drug Products Offered
    • 12.11.5 Bayer HealthCare Recent Development
  • 12.12 CoLucid
    • 12.12.1 CoLucid Corporation Information
    • 12.12.2 CoLucid Description and Business Overview
    • 12.12.3 CoLucid Sales, Revenue and Gross Margin (2015-2020)
    • 12.12.4 CoLucid Products Offered
    • 12.12.5 CoLucid Recent Development
  • 12.13 Daiichi Sankyo
    • 12.13.1 Daiichi Sankyo Corporation Information
    • 12.13.2 Daiichi Sankyo Description and Business Overview
    • 12.13.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
    • 12.13.4 Daiichi Sankyo Products Offered
    • 12.13.5 Daiichi Sankyo Recent Development
  • 12.14 Friggs
    • 12.14.1 Friggs Corporation Information
    • 12.14.2 Friggs Description and Business Overview
    • 12.14.3 Friggs Sales, Revenue and Gross Margin (2015-2020)
    • 12.14.4 Friggs Products Offered
    • 12.14.5 Friggs Recent Development
  • 12.15 DSM
    • 12.15.1 DSM Corporation Information
    • 12.15.2 DSM Description and Business Overview
    • 12.15.3 DSM Sales, Revenue and Gross Margin (2015-2020)
    • 12.15.4 DSM Products Offered
    • 12.15.5 DSM Recent Development
  • 12.16 Eisai
    • 12.16.1 Eisai Corporation Information
    • 12.16.2 Eisai Description and Business Overview
    • 12.16.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
    • 12.16.4 Eisai Products Offered
    • 12.16.5 Eisai Recent Development
  • 12.17 Eli Lilly
    • 12.17.1 Eli Lilly Corporation Information
    • 12.17.2 Eli Lilly Description and Business Overview
    • 12.17.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 12.17.4 Eli Lilly Products Offered
    • 12.17.5 Eli Lilly Recent Development
  • 12.18 Herbalife
    • 12.18.1 Herbalife Corporation Information
    • 12.18.2 Herbalife Description and Business Overview
    • 12.18.3 Herbalife Sales, Revenue and Gross Margin (2015-2020)
    • 12.18.4 Herbalife Products Offered
    • 12.18.5 Herbalife Recent Development
  • 12.19 Euradite
    • 12.19.1 Euradite Corporation Information
    • 12.19.2 Euradite Description and Business Overview
    • 12.19.3 Euradite Sales, Revenue and Gross Margin (2015-2020)
    • 12.19.4 Euradite Products Offered
    • 12.19.5 Euradite Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key OTC Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 OTC Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    OTC Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global OTC Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the OTC Drug market is segmented into
    Class A
    Class B

    Segment by Application, the OTC Drug market is segmented into
    Hospital
    Clinic
    Household

    Regional and Country-level Analysis
    The OTC Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the OTC Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and OTC Drug Market Share Analysis
    OTC Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in OTC Drug business, the date to enter into the OTC Drug market, OTC Drug product introduction, recent developments, etc.
    The major vendors covered:
    Bayer HealthCare
    GlaxoSmithKline (GSK)
    Johnson&Johnson
    Pfizer
    Sanofi
    AstraZeneca
    BioGaia
    Bristol Myers Squibb
    Bukwang Pharmaceutica
    Chr. Hansen
    Cipla
    CoLucid
    Daiichi Sankyo
    Friggs
    DSM
    Eisai
    Eli Lilly
    Herbalife
    Euradite

    Buy now